Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma
Apply
Pomalidomide with CD19CART
Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step